Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Recruiting 5Unknown 3Active not recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Adenoma, Islet Cell 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Pancreatectomy × Clear all
NCT02823678 2017-07-28

Pancreas Volume and Diabetes Status Following Pancreatectomy

Florida Hospital Tampa Bay Division

Unknown
100 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02117895 2016-08-11

Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail

Fudan University

Phase 3 Unknown
180 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02624154 2015-12-08

Pancreatic Neuroendocrine Tumor:Factor of Surgery Influencing Survival

First Affiliated Hospital, Sun Yat-Sen University

Unknown
2 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡